NR5A2 and type 1 diabetes mellitus: Given that LRH-1 can also be activated by smaller, non-polar bicyclic compounds18, we have synthesized a compound termed BL001, which we have tested in mouse models of T1DM, as well as in pancreatic islets from patients affected by Type 2 DM (T2DM).